Announcements, news, events, and other publications produced by our office.

The Harvard University Office of Technology Development (OTD) provides a one-stop shop to advance the development of groundbreaking discoveries by fostering strategic collaborations with industry through licensing, sponsored research and new venture agreements.

Impact

Turning today's discoveries into tomorrow's transformational technologies.

By serving as a catalyst bridging the laboratory to industry, OTD ensures that promising new technologies are developed into products and services that benefit society and transform the world.

Leadership

Leading the way in discovery and application.

Harvard is a recognized world leader in discovery and innovation. Leadership means the determination to see that new technologies developed at Harvard reach their full potential and push the boundaries of the new scientific and industrial frontier.

Experience

At OTD, experience is a competitive advantage.

OTD's high performance team provides a solid foundation in science, business development, intellectual property and contract law that enables it to design creative "win-win" solutions that translate into enduring, fruitful relationships. When industry turns to OTD, it will find an agile, fast-paced group of professionals fully equipped to find creative solutions and make the deal-making process as efficient and effective as possible.

Partnership

The power of collaborative partnering.

Partnership is a vital pillar, a linchpin of OTD's business model. We have the focus, commitment and expertise to forge creative and productive partnerships. OTD is dedicated to fostering win/win relationships between faculty and industry, investors and entrepreneurs, relationships that will provide mutual and long-lasting benefit.

Blavatnik Biomedical Accelerator

Propelling promising Harvard life science innovations to partnership

To positively impact society, biomedical technology breakthroughs must first make the leap from the research lab to the commercial sphere. The Blavatnik Biomedical Accelerator at Harvard University is uniquely structured to bridge that gap, helping propel groundbreaking innovations toward next-generation products.

Media Center

Welcome to the Harvard OTD Media Center. This section provides the latest news on OTD announcements, including new partnerships and agreements and also serves as the home for recent media coverage and details on upcoming events.

Press Releases

05.16.2013Evotec and Harvard University to collaborate on development of new class of antibacterials
04.22.2013Harvard startup, Learning CatalyticsTM is acquired by Pearson, the world’s leading learning company.
03.04.2013Life Technologies Signs License and Collaborative Stem Cell Research Agreement with Harvard University
10.10.2012UCB Announces Third Research Collaboration With Harvard University
07.10.2012CureBeta, a collaboration between Evotec and Harvard University enters strategic alliance with Janssen Pharmaceuticals

In the News

05.30.2013SiOnyx aims to become multi-billion dollar company in image-sensor tech
A startup company founded by Harvard researchers, the company has exclusive rights to license a Harvard-owned portfolio of patents, and is well poised to ramp up operations.
05.16.2013Pills Tracked From Doctor to Patient to Aid Drug Marketing
Activate Networks applies technology licensed from Harvard University to draw connections between physicians with patients in common.
04.29.2013$50M Gift From The Blavatnik Family Foundation
Blavatnik Biomedical Accelerator a catalyst to transform early-stage research [Click here for Boston Globe article.]
04.02.2013Harvard Startup, GnuBIO, Begins Shipment of Beta Systems
Established with leadership from Harvard’s Office of Technology Development, the newly formed startup company has begun the shipment of the World’s First Fully Integrated DNA Sequencing System.
03.11.2013Renewed Harvard-BASF initiative to advance functional materials
Established with leadership from Harvard’s Office of Technology Development, the new, multi-university initiative builds on the successful model pioneered by the BASF Advanced Research Initiative that was based at Harvard SEAS from October 2007 to present.